These emerging medications , Semaglutide , represent a groundbreaking advancement in treating metabolic dysfunction and possibly related disorders. These drugs are classified as GLP-1 hormone activators , indicating they function to mimic the body's GLP-1 hormone , boosting metabolic secretion and lowering appetite . Although Retatrutide each on… Read More